Overall rank by patents
#24,174
Across all tracked assignees
USPTO PatentsView assignee record - 11 granted patents across 7 technology areas, active 2018–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G06F (ELECTRIC DIGITAL DATA PROCESSING).
The verdict
Cyborg holds 11 US patents across 7 technology areas, rank #24,174 of 50,000 tracked assignees.
Cyborg Inc. has been granted 11 US utility patents between 2018 and 2024, placing Cyborg Inc. at rank #24,174 across all assignees tracked by PlainPatent. This portfolio spans 7 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.1 claims per patent with primary concentration in G06F (ELECTRIC DIGITAL DATA PROCESSING). As a US Corporation, Cyborg Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Cyborg sits between Cross Commerce Media, Inc. (11 patents, rank #24,170) and Daihachi Chemical Industry Co., Ltd. (11 patents, rank #24,178) - the closest US assignees by grant volume. The composite Innovation Score of 34.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 7 grants, compared with 4 in the 2015–2019 window, a +75% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Cyborg Inc.'s 18.1 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 7 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Cyborg Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Cross Commerce Media, Inc.
11 patents
Cure Pharmaceutical Holding Corp.
11 patents
CureVac Manufacturing GmbH
11 patents
Cyalume Technologies, Inc.
11 patents
D-FEND SOLUTIONS AD LTD.
11 patents
DAEJOO ELECTRONIC MATERIALS CO., LTD.
11 patents
DAEWOONG CO., LTD.
11 patents
DAIHACHI CHEMICAL INDUSTRY CO., LTD.
11 patents
Cyborg Inc.
11 patents
What this shows Cyborg holds 11 patents at rank #24,174, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Cyborg's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
34 Top 53% higher than 47% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 2 | 18.2% |
| 2019 | 2 | 18.2% |
| 2021 | 3 | 27.3% |
| 2022 | 2 | 18.2% |
| 2024 | 2 | 18.2% |
Top 7 of 7 technology areas
Overall rank by patents
#24,174
Across all tracked assignees
34.1 out of 100
How to use this portfolio
Cyborg's 11 grants land it in the top 53% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.